SecSonar.com

Niagen Bioscience Inc (NAGE)

Niagen Bioscience Inc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Niagen Bioscience Inc (NAGE) is a Biotechnology company based in US with a market capitalization of $311.8M. Revenue grew 29.9% year-over-year and the company generated $13.1M in free cash flow. This page tracks NAGE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 104 employees · IPO Jun 24, 2015

Valuation

Valuation & price

$3.65 · as of May 17, 2026 · -70.7% vs 52w high

17.9

P/E ratio

Latest-FY diluted EPS

4.07

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$12.44$7.88$3.33Jul 25Dec 25Jun 26Jul 7, 25$12.44Jul 9, 25$12.12Jul 11, 25$11.30Jul 15, 25$11.08Jul 17, 25$10.36Jul 21, 25$9.68Jul 23, 25$9.86Jul 25, 25$9.32Jul 29, 25$9.66Jul 31, 25$9.35Aug 4, 25$9.64Aug 6, 25$9.40Aug 8, 25$9.73Aug 12, 25$10.26Aug 14, 25$9.71Aug 18, 25$10.12Aug 20, 25$9.63Aug 22, 25$9.98Aug 27, 25$9.77Aug 29, 25$9.90Sep 3, 25$9.67Sep 5, 25$9.41Sep 9, 25$9.38Sep 11, 25$9.62Sep 15, 25$9.68Sep 17, 25$9.63Sep 19, 25$9.86Sep 23, 25$10.20Sep 25, 25$9.41Sep 29, 25$9.90Oct 1, 25$7.89Oct 3, 25$6.93Oct 7, 25$7.18Oct 9, 25$7.56Oct 13, 25$7.46Oct 16, 25$7.42Oct 20, 25$7.21Oct 22, 25$7.43Oct 24, 25$7.57Oct 28, 25$7.27Oct 30, 25$7.11Nov 3, 25$7.23Nov 5, 25$6.88Nov 7, 25$6.84Nov 11, 25$7.16Nov 13, 25$6.99Nov 17, 25$6.93Nov 19, 25$6.90Nov 21, 25$6.88Nov 25, 25$7.04Nov 28, 25$6.77Dec 2, 25$6.40Dec 5, 25$6.45Dec 9, 25$6.51Dec 11, 25$6.63Dec 15, 25$6.37Dec 17, 25$6.29Dec 19, 25$6.52Dec 23, 25$6.51Dec 26, 25$6.64Dec 30, 25$6.48Jan 2, 26$6.25Jan 6, 26$6.76Jan 8, 26$6.56Jan 12, 26$6.39Jan 14, 26$6.31Jan 16, 26$6.19Jan 21, 26$6.20Jan 23, 26$6.01Jan 28, 26$6.03Jan 30, 26$5.99Feb 3, 26$5.68Feb 5, 26$5.13Feb 9, 26$5.10Feb 11, 26$5.11Feb 13, 26$5.14Feb 18, 26$5.00Feb 20, 26$4.86Feb 24, 26$5.11Feb 26, 26$5.18Mar 2, 26$4.99Mar 4, 26$4.94Mar 6, 26$5.06Mar 10, 26$5.22Mar 12, 26$4.82Mar 16, 26$4.80Mar 19, 26$4.74Mar 23, 26$4.71Mar 25, 26$4.52Mar 27, 26$4.20Mar 31, 26$4.41Apr 2, 26$4.38Apr 7, 26$4.47Apr 9, 26$4.48Apr 13, 26$4.61Apr 15, 26$4.74Apr 17, 26$4.84Apr 21, 26$4.74Apr 23, 26$4.73Apr 27, 26$4.96Apr 29, 26$4.76May 1, 26$4.85May 5, 26$4.82May 8, 26$4.17May 12, 26$3.85May 14, 26$3.80May 18, 26$3.70May 20, 26$3.75May 22, 26$3.66May 27, 26$3.83May 29, 26$3.86Jun 2, 26$3.54Jun 4, 26$3.50Jun 8, 26$3.37Jun 10, 26$3.47Jun 12, 26$3.45Jun 16, 26$3.43Jun 18, 26$3.50Jun 23, 26$3.38Jun 29, 26$3.33
$3.3152-week range$12.44
Loading valuation history…

Fundamentals

Key fundamentals

$311.8M

Market cap

29.9%

Revenue growth (YoY)

64.3%

Gross margin

$13.1M

Free cash flow (USD)

-$62M

Net debt

Net cash position

-7.3%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$21.7MFY 2017$21.2MFY 2018$31.6MFY 2019$46.3MFY 2020$59.3MFY 2021$67.4MFY 2022$72.0MFY 2023$83.6MFY 2024$99.6MFY 2025$129.4M
$21.7M$129.4M

Free cash flow by year

2016 → 2025

FY 2016$-4.7MFY 2017$-11.2MFY 2018$-22.4MFY 2019$-21.2MFY 2020$-10.7MFY 2021$-24.6MFY 2022$-15.4MFY 2023$7.0MFY 2024$11.9MFY 2025$13.1M
-$4.7M$13.1M

Gross margin by year

2021 → 2025

FY 202161.5%FY 202259.4%FY 202360.8%FY 202461.8%FY 202564.3%
61.5%64.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 29, 2026Filing
  • FinancingSecurities RegistrationJun 26, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing

Questions

Frequently asked questions

What is Niagen Bioscience Inc's market cap?

Niagen Bioscience Inc (NAGE) has a market capitalization of $311.8M.

What is NAGE's P/E ratio?

NAGE trades at a price-to-earnings ratio of 17.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is NAGE's price-to-book (P/B) ratio?

NAGE trades at 4.07 times book value per share.

Are insiders buying NAGE stock?

SEC Form 4 filings show no open-market insider buys at Niagen Bioscience Inc in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

XOMAP

XOMA Corporation

$307M

FATE

Fate Therapeutics, Inc.

$317M

ENTA

Enanta Pharmaceuticals, Inc.

$305.7M

VSTM

Verastem, Inc.

$303.9M

SLN

Silence Therapeutics plc

$320.4M

AMRN

Amarin Corporation plc

$302.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.